Welcome to the website for the FASST (For a Systemic Sclerosis Treatment) clinical trial.
You will find here detailed information on this phase 2 clinical trial sponsored by Inventiva Pharma. The purpose of this study is to evaluate the effectiveness and safety of IVA337 for the treatment of Diffuse Cutaneous Systemic Sclerosis.
For the investigational sites, you can login to the protected area of the site to access the trial useful documents and recent news.
We hope this website will provide you with sufficient information to meet your needs. Please feel free to contact us if you have any questions.
Please note that this website is intended for information purposes only. It is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.
FASST Principal Investigators:
Prof. Yannick Allanore, Paris Descartes University, Paris
Prof. Chris Denton, Royal Free Hospital, London